Novel PKC-ζ to p47phox interaction is necessary for transformation from blebbishields
Goodwin G. Jinesh(The University of Texas MD Anderson Cancer Center), Ashish M. Kamat(The University of Texas MD Anderson Cancer Center)
Cited by 23
Related Papers
Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study
|The Lancet Oncology|2021|532
Recurrence mechanisms of non-muscle-invasive bladder cancer — a clinical perspective
|Nature Reviews Urology|2022|196
1,1-Bis(3′-indolyl)-1-( <i>p</i> -chlorophenyl)methane activates the orphan nuclear receptor Nurr1 and inhibits bladder cancer growth
|Molecular Cancer Therapeutics|2008|104
Molecular genetics and cellular events of K-Ras-driven tumorigenesis
|Oncogene|2017|95
Blebbishields, the emergency program for cancer stem cells: sphere formation and tumorigenesis after apoptosis
|Cell Death and Differentiation|2012|58